Global Levothyroxine Market is segmented based on product type, dosage form, application, and region. Levothyroxine is also called as L-thyroxine that is it is a synthetic form of thyroxine (T4). To regulate the body’s mechanism thyroid medicine known as Levothyroxine helps to replaces or provide a thyroid hormone produced by thyroid gland. For maintaining normal mental and physical activity, having enough thyroid hormone is important.
Levothyroxine is used to treat hypothyroidism, congenital hypothyroidism (cretinism), and goiter (enlarged thyroid gland). It is also used to treat thyroid cancer using surgery and radioactive iodine therapy. The thyroxine (T4) and tri-iodothyronine (T3) are the two thyroid hormones are generally produced and released. T3 is the active thyroid hormone, and thyroxine is transformed into T3 in several parts of the body. These hormones are responsible for continuing a normal rate of metabolism in the body.
The factors that affects body in the absence of thyroid hormone are, slow speech, poor growth, excessive tiredness, hair loss, dry thick skin, lack of energy, constipation, weight gain, heavy or irregular menstrual periods, depression, and increased sensitivity to cold, joint and muscle pain. The active ingredient that makes the tablets work is anhydrous levothyroxine sodium. 50 micrograms or 100 micrograms of the active substance is present in each tablet. Regular blood tests help to monitor thyroid hormone levels while taking levothyroxine.
Levothyroxine Market is classified, by product type into Tablet, and intravenous Injection. Levothyroxine tablets are used to treat hypothyroidism, pituitary TSH Suppression, and Contraindications. Levothyroxine sodium tablets, USP contain synthetic crystalline L-3,3’,5,5’- tetraiodothyronine sodium salt.
Levothyroxine Market is classified, by dosage forms into Solution, Capsule, Liquid Filled, and Tablet. The Tirosint is an only drug in the form of capsule. Whereas, tablets are available as generic drugs, generally cost less. Eltroxin Oral Solution is a liquid form of levothyroxine that comes in three strengths, 25mcg, 50mcg, and 100mcg.
Levothyroxine Market is classified, by application into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and others. Levothyroxine Market is segmented, geographically into North America, Europe (Eastern Europe, Western Europe), Asia Pacific, Latin America, Middle East and Africa. Levothyroxine Market key players are Alara Pharm, FOREST, PIRAMAL HEALTHCARE, MERCK SERONO, Mylan and Abbott Ltd.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Levothyroxine in these regions, from 2013 to 2025 (forecast), covering
• North America
• Southeast Asia
Global Levothyroxine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• LGM Pharma
• Taj Group
• Merck Serono
• Bhaarat Pharmaceutical
• Manus Aktteva
• Shenzhen Zhonglian Pharmaceutical
• Sichuan Hairong Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Intravenous Injection
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Research Support Specialist, USA